Tex. Health & Safety Code § 491.051 · Subchapter B. ELIGIBLE PATIENT ACCESS TO INVESTIGATIONAL SUN PROTECTION PRODUCTS
PATIENT ELIGIBILITY.
Text — Current through the 89th 2nd Called Legislative Session, 2025
A patient is eligible to access and use an investigational sun protection product if the patient's physician:
(1) in consultation with the patient, has considered all other sun protection products currently approved by the United States Food and Drug Administration and determined those products are less effective in comparison to an investigational sun protection product; and
(2) recommends or prescribes in writing an investigational sun protection product for the patient.
Notes and commentary — not statutory text
History
Added by Acts 2025, 89th Leg., R.S., Ch. 352 (S.B. 670), Sec. 2, eff. June 20, 2025.
Source of truth
- Edition
- Current through the 89th 2nd Called Legislative Session, 2025
- Official file
- https://statutes.capitol.texas.gov/Docs/HS/htm/HS.491.V2.htm
- Text hash
- sha256 57b6762033204dee2a7845f7a391001fedfc5def06015207dd25e0adf672e518
- Composed by
- compose_tx.py 2026-10-05: the Legislative Council's chapter files read in document order; verify_tx.py's independent reading (lxml DOM walk) agrees character for character
- the Legislature enacted more than one unit numbered 491.051; this is the one the Council prints in hs.491.v2.htm
Procedural information only. Not legal advice and not a substitute for the advice of an attorney. Confirm the current text with the official publisher before relying on it.